Expanded Access for Fixed-Dose Combination of Nivolumab Plus Relatlimab
- Registration Number
- NCT05170685
- Lead Sponsor
- Bristol-Myers Squibb
- Brief Summary
This is an expanded access designed to provide access to fixed-dose combination of nivolumab plus relatlimab for eligible participants.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NO_LONGER_AVAILABLE
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- EXPANDED_ACCESS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method